TrialPharmacoEconomics2010

Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial.

Edward C F Wilson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.